AL
Eurofins-Cerep S.A.
ALECR.PA · PAR
16,100.00 € +0.00% (+0.00 €)
Market Cap 81.2M €
P/E Ratio 11.35x
Div. Yield -
ROE -
Bulios Fair Price
9,594 €
40.4% downside
Current Price
16,100 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALECR.PA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
95 /100
Cheap P/E 11.35x
P/B 1.13x
EV/EBITDA 7.20x
Growth
95 /100
Growing EPS growth 38.16%
Book val. growth 24.45%
Rev. growth 15.38%
Profitability
53 /100
Moderate Gross margin 43.14%
FCF margin 0.00%
Net margin 17.68%
Quality
46 /100
Average ROIC 6.73%
Asset turnover 0.48x
ROA 8.51%
Debt
100 /100
Low Debt/Equity 0.00x
Net debt/EBITDA -1.94x
Current ratio 6.94x
Stability
60 /100
Moderate Beta 0.01x
Profitable years 6
Rev. volatility 11.08%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALECR.PA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Damien Vielliard
Employees
209
Headquarters
Vienne